Page last updated: 2024-08-24

lamivudine and Complication, Postoperative

lamivudine has been researched along with Complication, Postoperative in 84 studies

Research

Studies (84)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	11 (13.10)	18.2507
2000's	63 (75.00)	29.6817
2010's	9 (10.71)	24.3611
2020's	1 (1.19)	2.80

Authors

Authors	Studies
Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y	1
Chen, CL; Li, WF; Lin, CC; Lin, LM; Lin, TL; Lin, YH; Loh, PY; Wang, SH	1
Padma, UD; Surendran, S; Udayakumar, VP	1
Alexopoulos, S; Kasraianfard, A; Lindberg, L; Rezaei, N; Watt, KD	1
Avihingsanon, Y; Chancharoenthana, W; Eiam-Ong, S; Kittikowit, W; Kittiskulnam, P; Leelahavanichkul, A; Pongpirul, K; Praditpornsilpa, K; Suankratay, C; Townamchai, N; Tungsanga, K; Wattanatorn, S	1
Choi, GH; Choi, JS; Joo, DJ; Ju, MK; Kim, MS; Kim, SI; Lee, J; Lee, JG; Lee, JJ; Song, SH	1
Aliosmanoglu, I; Cetinkaya, R; Erbis, H; Kocak, H; Suleymanlar, G; Ulger, BV; Yilmaz, VT	1
Akyildiz, M; Balci, D; Cinar, K; Dayangac, M; Gungor, G; Hazinedaroglu, S; Idilman, R; Kalkan, C; Keskin, O; Tokat, Y; Yilmaz, TU	1
Ba, MC; Cui, SZ; Li, ML; Lu, Q; Shi, HJ; Tang, YQ; Wang, B; Wang, JK; Wu, YB; Zhang, XL; Zhao, HY; Zhu, XF	1
Angus, PW; Gane, E; McCaughan, GW; Patterson, SJ; Strasser, SI	1
Casoli, V; Délia, G; Martin, D; Rousvoal, A	1
Chen, ZY; Li, B; Li, G; Ma, YK; Wang, WT; Wen, TF; Wu, H; Xu, MQ; Yan, LN; Yang, JY; Zeng, Y; Zhao, JC	1
Rizzetto, M	1
Samuel, D	1
Mas, A	1
Chen, XS; Han, LZ; Luo, Y; Qiu, DK; Shen, CH; Wang, SY; Wang, X; Xi, ZF; Xia, Q; Xin, TY; Zhang, JJ	1
Ahn, JS; Choi, MS; Gwak, GY; Im, YH; Kang, ES; Kim, KH; Lee, JE; Nam, SJ; Park, YH; Yang, JH; Yun, J	1
Akbas, E; Aktas, S; Atiq, A; Haberal, M; Karakayali, H; Selcuk, H; Sevmis, S; Zia, HH	1
Huang, D; Liang, T; Lu, A; Wang, W; Wu, J; Zheng, S	1
Berg, T; Jonas, S; Müller, AR; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D; Settmacher, U; Steinmüller, T	1
Lok, AS	1
Chan, TM; Cheng, IK; Fang, GX; Ho, SK; Lai, KN; Tang, CS	1
Anderson, ML; Kawanishi, H; Shah, N; Vasseur, BG	1
Fontana, RJ; Lok, AS	1
Chan, HW; Tong, KL; Tsang, WK	1
Burroughs, AK; Papatheodoridis, GV; Sevastianos, V	1
Bernardos, A; Cañas, E; Díaz, C; García, I; Gómez, MA; Hinojosa, R; Martín, C; Pareja, F; Pascasio, JM; Pérez-Bernal, JB; Sayago, M; Serrano, J; Sousa, JM; Tamayo, MJ	1
Ben-Ari, Z; Mor, E; Tur-Kaspa, R	1
Andreone, P; Bernardi, M; Biselli, M; Cursaro, C; Gramenzi, A; Lorenzini, S	1
Li, B; Li, XD; Lin, QY; Liu, C; Liu, J; Lu, SC; Ma, YK; Qing, S; Wang, XB; Wen, TF; Yan, LN; Zhang, XH; Zhao, JC; Zhao, LS	1
Huang, DS; Liang, TB; Wang, WL; Wu, J; Xu, X; Zheng, SS	1
Alavian, SM; Einollahi, B; Hajarizadeh, B	1
Bunnapradist, S; Dixit, V; Dulai, G; Fabrizi, F; Martin, P	1
Zhang, TL	1
Chen, XS; Ding, GS; Fu, H; Fu, ZR; Guo, WY; Shi, XM; Wang, ZX; Zhang, JJ	1
Da Costa, M; Dan, YY; Isaac, J; Lee, HL; Lee, KH; Lee, YM; Lim, SG; Mak, K; Prabhakaran, K; Sutedja, DS; Wai, CT; Wee, A	1
Liu, C; Lu, Y; Pan, CE; Wang, B; Wu, Z; Yu, L	1
Cotler, SJ; Mohanty, SR	1
Cheema, FH; Chen, JM; Edwards, NM; Hammond, K; Mancini, D; Pinney, SP	1
Shen, ZY	1
Brown, RS; Brundage, R; Dickson, RC; Fried, M; Horwith, G; Ishitani, M; Jensen, D; Lok, A; Luketic, V; Reddy, KR; Sheiner, P; Soldevila-Pico, C; Terrault, NA	1
Chen, Y; Liang, T; Lu, A; Shen, Y; Wang, W; Zhang, M; Zheng, S	1
Eisenbach, C; Encke, J; Mehrabi, A; Sauer, P; Stremmel, W	1
Dassanayake, AS; de Silva, AP; de Silva, HJ; Manamperi, A	1
Angus, PW; Crawford, DH; Gane, EJ; Jeffrey, GP; McCaughan, GW; Ring, J; Strasser, S	1
Agnelli, F; Caccamo, L; Donato, MF; Gatti, S; Maggi, U; Melada, E; Paone, G; Reggiani, P; Rossi, G	1
Busuttil, RW; Cameron, AM; Ghobrial, RM; Hiatt, JR; Tong, MJ; Zimmerman, MA	1
Alves-Filho, G; Lorena, SL; Mazzali, M; Sevá-Pereira, T; Soares, EC; Urbini Dos Santos, C	1
Bain, VG; Fischer, KP; Kneteman, NM; Ma, MM; Tipples, GA; Tyrrell, DL	1
Niederau, C	1
Bain, VG; Davis, JE; Erb, SR; Fischer, KP; Kneteman, NM; Ma, MM; Tyrrell, DL; Yoshida, EM	1
Arnold, JC; Golling, M; Herfarth, C; Otto, G; Rudek, B; Theilmann, L	1
Herrero, JI; Pardo, F; Prieto, J; Quiroga, J; Riezu-Boj, JI; Sangro, B; Sola, I	1
Condreay, L; Debernardi-Venon, W; Marzano, A; Rizzetto, M	1
Artinian, L; Busuttil, RW; Conrad, AJ; Goldstein, LI; Goss, JA; Holt, C; Imagawa, DK; Markmann, JF; Markowitz, JS; Martin, P; Murray, NG; Pakrasi, A; Schmidt, P; Seu, P; Stribling, R; Yersiz, H	1
Cornu, C; Goffin, E; Horsmans, Y; Pirson, Y; Squifflet, JP	1
Anschuetz, G; Brown, N; Caldwell, S; Crowther, L; Dienstag, J; Farr, G; Gish, R; Levy, G; Martin, P; Perrillo, R; Rakela, J; Schiff, E; Villeneuve, JP; Wright, T	1
Bárcena, R; del Campo, S; Domínguez-Antonaya, M; López-Sanromán, A; Martínez-Turnes, A; Moreno, N; Urman, J	1
Briceno, MN; Garcia-Kennedy, R; Gish, RR; Osorio, RW; Poordad, FF; Roberts, JP; Yao, FY	1
Boxall, L; Buchan, S; Cane, P; Elias, E; Hübscher, S; Martin, B; Mutimer, D; O'Donnell, K; Pillay, D; Ratcliffe, D; Shaw, J; Shields, P	1
Al Asghar, H; Cattral, MS; Greig, PD; Hemming, AW; Humar, A; Levy, GA; Lilly, LB; Malkan, G	1
Bordin, V; Catalano, C; Di Landro, D; Fabbian, F; Manani, SM; Vogel, W	1
Bechstein, WO; Berg, T; Hopf, U; Müller, AR; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D	1
Sherlock, CH; Yoshida, EM	1
Angus, PW; Crawford, DH; Gane, EJ; Harley, H; McCaughan, GW	1
Bonham, CA; de Vera, ME; Dodson, SF; Fung, JJ; Geller, DA; Rakela, J	1
Ciecierski, R; Cieciura, T; Durlik, M; Kukuła, K; Lao, M; Lewandowska, D; Rowiński, W; Szmidt, J; Walewska-Zielecka, B	1
Bechstein, WO; Berg, T; Müller, AR; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D	1
Hu, RH; Lai, MY; Lee, CJ; Lee, PH; Tsai, MK	1
Fischer, L; Rogiers, X; Sterneck, M; Zöllner, B	1
Bernard, B; Bitker, MO; Coriat, P; Mouquet, C; Opolon, P; Poynard, T; Thibault, V	1
Ben-Ari, Z; Mor, E; Shapira, Z; Tur-Kaspa, R	1
Lim, SG; Tan, KC; Wai, CT	2
Vargas, HE	1
Cahlin, C; Friman, S; Olausson, M	2
Bar-Nathan, N; Ben-Ari, Z; Dinari, G; Mor, E; Shapira, R; Sokal, EM; Tur-Kaspa, R	1
Baruch, Y; Gelman, R; Green, J; Khankin, E; Nakhoul, F	1
Leung, N	1
Chen, DS; Chen, PJ; Chou, NK; Chu, SH; Jen, YM; Kao, JH; Lai, MY; Lee, PH; Liu, CJ	1
Pol, S	1
Chan, TM; Ho, SK; Lai, KN; Moniri, K; Tang, S	1
Huang, D; Liang, T; Liao Sy, SY; Lu Aw, AW; Shen, Y; Wang, W; Wu, J; Xu, X; Zhang, M; Zheng, S	1

Reviews

14 review(s) available for lamivudine and Complication, Postoperative

Article	Year
Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2 Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea	2022
HBIG Remains Significant in the Era of New Potent Nucleoside Analogues for Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation. International reviews of immunology, 2016, 07-03, Volume: 35, Issue:4 Topics: Animals; Combined Modality Therapy; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Postoperative Complications	2016
[Adipose tissue hypertrophy after Lipostructure in HIV patient with antiretroviral treatment. Case report and literature review]. Annales de chirurgie plastique et esthetique, 2009, Volume: 54, Issue:4 Topics: Adipose Tissue; Adult; Anti-Retroviral Agents; Drug Combinations; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Hypertrophy; Lamivudine; Male; Postoperative Complications; Zidovudine	2009
The option of liver transplantation for hepatitis B: where are we? Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2009, Volume: 41 Suppl 2 Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Organophosphonates; Postoperative Complications; Practice Guidelines as Topic; Secondary Prevention; Viral Load	2009
Liver transplantation for hepatitis B virus. Pre-emptive and peri-operative prophylaxis. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2009, Volume: 41 Suppl 2 Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Organophosphonates; Perioperative Care; Postoperative Complications; Secondary Prevention; Treatment Outcome	2009
Prevention of recurrent hepatitis B post-liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2002, Volume: 8, Issue:10 Suppl 1 Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Organophosphonates; Postoperative Complications; Reverse Transcriptase Inhibitors; Secondary Prevention; Viral Hepatitis Vaccines	2002
Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2003, Volume: 3, Issue:3 Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Nucleosides; Organophosphonates; Postoperative Complications; Recurrence; Time Factors; Transplantation Immunology	2003
Experience with lamivudine therapy for hepatitis B virus infection before and after liver transplantation, and review of the literature. Journal of internal medicine, 2003, Volume: 253, Issue:5 Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Treatment Outcome; Virus Replication	2003
Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: meta-analysis of clinical trials. Transplantation, 2004, Mar-27, Volume: 77, Issue:6 Topics: DNA, Viral; Hepatitis B; Humans; Kidney Transplantation; Lamivudine; MEDLINE; Postoperative Complications	2004
Management of hepatitis B in liver transplant patients. Journal of clinical gastroenterology, 2005, Volume: 39, Issue:1 Topics: Antiviral Agents; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Postoperative Complications; Recurrence; Risk Factors	2005
Prevention of hepatitis B virus recurrence after liver transplantation. Clinical transplantation, 2006, Volume: 20 Suppl 17 Topics: Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Postoperative Complications; Reverse Transcriptase Inhibitors; Secondary Prevention	2006
Lamivudine for treating active hepatitis B in renal transplant recipients: a case report. Clinical nephrology, 2000, Volume: 53, Issue:4 Topics: Hepatitis B; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Postoperative Complications; Reverse Transcriptase Inhibitors	2000
Lamivudine therapy for severe acute hepatitis B virus infection after renal transplantation: case report and literature review. Transplantation proceedings, 2001, Volume: 33, Issue:6 Topics: Hepatitis B; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Male; Middle Aged; Postoperative Complications; Reverse Transcriptase Inhibitors	2001
[HVB and HVC infections in nephrology]. Nephrologie, 2001, Volume: 22, Issue:6 Topics: Antiviral Agents; Comorbidity; Contraindications; Graft Rejection; Hepatitis B; Hepatitis C; Humans; Immunosuppression Therapy; Interferon-alpha; Kidney Diseases; Kidney Transplantation; Lamivudine; Liver Cirrhosis; Postoperative Complications; Renal Dialysis; Ribavirin; Vaccination; Viral Hepatitis Vaccines; Viremia	2001

Trials

12 trial(s) available for lamivudine and Complication, Postoperative

Article	Year
Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2 Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea	2022
Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2017, Volume: 23, Issue:10 Topics: Adult; Allografts; Antibiotic Prophylaxis; Antiviral Agents; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Incidence; Lamivudine; Liver; Liver Transplantation; Living Donors; Male; Middle Aged; Postoperative Complications; Serologic Tests; Treatment Outcome; Vaccination	2017
A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis. Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:5 Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Patient Selection; Postoperative Complications; Viral Load	2008
The role of entecavir in preventing hepatitis B recurrence after liver transplantation. Journal of digestive diseases, 2009, Volume: 10, Issue:4 Topics: Adult; Aged; Antiviral Agents; DNA, Viral; Female; Follow-Up Studies; Guanine; Hepatitis Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Reverse Transcriptase Inhibitors; Secondary Prevention	2009
[Lamivudine as prophylaxis against hepatitis B virus reinfection following orthotopic liver transplantation]. Zhonghua yi xue za zhi, 2002, Apr-10, Volume: 82, Issue:7 Topics: Adult; Antiviral Agents; Chemoprevention; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Postoperative Complications	2002
Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients. Hepatology (Baltimore, Md.), 2002, Volume: 36, Issue:5 Topics: Adult; DNA, Viral; Drug Resistance, Viral; Female; Graft Survival; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Postoperative Complications; Prospective Studies; Recurrence; Reverse Transcriptase Inhibitors; Transplantation, Homologous; Treatment Outcome; Virus Replication	2002
Lamivudine therapy in renal allograft recipients with hepatitis B virus infection. Transplantation proceedings, 2003, Volume: 35, Issue:1 Topics: Adult; Antiviral Agents; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Male; Postoperative Complications; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors; Virus Activation	2003
Dynamic alteration of HBV markers on active HBV replicative recipients after liver transplantation: a preliminary report. Hepatobiliary & pancreatic diseases international : HBPD INT, 2003, Volume: 2, Issue:2 Topics: Adult; Aged; Biomarkers; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Prospective Studies; Recurrence; Reverse Transcriptase Inhibitors; Virus Replication	2003
Lamivudine in prevention and treatment of recurrent HBV after liver transplantation. Hepatobiliary & pancreatic diseases international : HBPD INT, 2004, Volume: 3, Issue:4 Topics: Adult; Female; Follow-Up Studies; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Reverse Transcriptase Inhibitors; Secondary Prevention; Treatment Outcome	2004
Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2006, Volume: 12, Issue:1 Topics: Adult; Aged; Analysis of Variance; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Hepatitis B Antibodies; Hepatitis B, Chronic; Humans; Immunoglobulins; Infusions, Intravenous; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Prospective Studies; Risk Assessment; Secondary Prevention; Transplantation Immunology; Treatment Outcome	2006
Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group. Hepatology (Baltimore, Md.), 1999, Volume: 29, Issue:5 Topics: Adult; Aged; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Postoperative Complications	1999
Treatment of chronic hepatitis B with lamivudine in renal allograft recipients. Transplantation proceedings, 2000, Volume: 32, Issue:6 Topics: Adult; Aged; Antiviral Agents; Biopsy; Female; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Postoperative Complications	2000

Other Studies

59 other study(ies) available for lamivudine and Complication, Postoperative

Article	Year
Utilization of hepatitis B core antibody positive grafts in living donor liver transplantation. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2018, Volume: 37, Issue:1 Topics: Adolescent; Adult; Antiviral Agents; Female; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Living Donors; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Risk; Tenofovir; Transplants; Virus Activation; Young Adult	2018
The outcomes of kidney transplantation in hepatitis B surface antigen (HBsAg)-negative recipients receiving graft from HBsAg-positive donors: a retrospective, propensity score-matched study. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2014, Volume: 14, Issue:12 Topics: Adult; Antiviral Agents; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Incidence; Kidney Failure, Chronic; Kidney Function Tests; Kidney Transplantation; Lamivudine; Longitudinal Studies; Male; Middle Aged; Postoperative Complications; Prognosis; Propensity Score; Retrospective Studies; Risk Factors; Thailand; Tissue Donors	2014
Adefovir- or Lamivudine-Induced Renal Tubular Dysfunction after Liver Transplantation. Medicine, 2015, Volume: 94, Issue:38 Topics: Adenine; Female; Hepatitis B; Humans; Incidence; Kidney Diseases; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Postoperative Complications; Recurrence; Republic of Korea; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors	2015
Effects of hepatitis B surface antigen (HBsAg) positivity of donors in HBsAg(+) renal transplant recipients: comparison of outcomes with HBsAg(+) and HBsAg(-) donors. Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:1 Topics: Adult; Antiviral Agents; Female; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Liver; Male; Middle Aged; Postoperative Complications; Tenofovir; Tissue Donors; Transplant Recipients	2016
The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence. Clinical transplantation, 2016, Volume: 30, Issue:10 Topics: Adenine; Administration, Oral; Adult; Aged; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B, Chronic; Humans; Immunoglobulins; Immunologic Factors; Kaplan-Meier Estimate; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Postoperative Complications; Proportional Hazards Models; Recurrence; Retrospective Studies; Tenofovir; Treatment Outcome	2016
[Prevention and treatment of hepatitis B recurrence after liver transplantation]. Zhonghua yi xue za zhi, 2008, Mar-04, Volume: 88, Issue:9 Topics: Adult; Antiviral Agents; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Secondary Prevention	2008
[Evaluation of the effect of living donor liver transplantation on the treatment of severe hepatitis]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2009, Volume: 17, Issue:3 Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Follow-Up Studies; Hepatitis B; Humans; Immunoglobulins; Immunosuppressive Agents; Kidney Function Tests; Lamivudine; Liver Cirrhosis; Liver Function Tests; Liver Transplantation; Living Donors; Male; Middle Aged; Postoperative Complications; Postoperative Period; Treatment Outcome; Young Adult	2009
Liver transplantation and management of the hepatitis B virus. Preface. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2009, Volume: 41 Suppl 2 Topics: Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Postoperative Complications; Secondary Prevention	2009
Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy. British journal of cancer, 2011, Feb-15, Volume: 104, Issue:4 Topics: Adult; Aged; Algorithms; Anthracyclines; Antibiotic Prophylaxis; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Breast Neoplasms; Carcinoma; Case-Control Studies; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Female; Hepatitis B; Humans; Incidence; Lamivudine; Middle Aged; Postoperative Complications; Retrospective Studies	2011
Long-term results of hepatitis B immunoglobulin and lamuvidine for hepatitis B prophylaxis after liver transplantation. Transplantation proceedings, 2011, Volume: 43, Issue:2 Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunoglobulins; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors	2011
Combination prophylaxis with Hepatitis B immunoglobulin and lamivudine after liver transplantation minimizes HBV recurrence rates unless evolution of pretransplant lamivudine resistance. Zeitschrift fur Gastroenterologie, 2002, Volume: 40, Issue:9 Topics: Adult; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Follow-Up Studies; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Reverse Transcriptase Inhibitors; Virus Replication	2002
Type B lactic acidosis: a rare complication of antiretroviral therapy after cardiac surgery. The Annals of thoracic surgery, 2002, Volume: 74, Issue:4 Topics: Acidosis, Lactic; Anti-HIV Agents; Aortic Valve; Female; Heart Valve Prosthesis; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Kidney Failure, Chronic; Lamivudine; Middle Aged; Postoperative Complications; Renal Dialysis; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine	2002
Combination of HBIG and lamivudine-resistant mutations: a formula for trouble? Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2002, Volume: 8, Issue:11 Topics: DNA-Directed DNA Polymerase; Drug Resistance; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Mutation; Postoperative Complications; Reverse Transcriptase Inhibitors; Virus Replication	2002
Comparison between levels of anti-HBS with a fixed administration dose of HBIG and a combination of HBIG and lamivudine for the prophylaxis of hepatitis B after liver transplantation. Transplantation proceedings, 2003, Volume: 35, Issue:2 Topics: Adult; Aged; Antibodies, Viral; Antiviral Agents; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Middle Aged; Postoperative Complications; Recurrence; Retrospective Studies	2003
Prophylaxis and treatment of hepatis B virus infection after liver transplantation. Transplantation proceedings, 2003, Volume: 35, Issue:3 Topics: Antiviral Agents; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Postoperative Complications	2003
Prophylaxis and treatment of hepatitis B virus reinfection following liver transplantation. Hepatobiliary & pancreatic diseases international : HBPD INT, 2002, Volume: 1, Issue:3 Topics: 2-Aminopurine; Adult; Antiviral Agents; DNA, Viral; Dose-Response Relationship, Drug; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Postoperative Complications; Reverse Transcriptase Inhibitors; Secondary Prevention	2002
Efficacy and safety of lamivudine for treatment of chronic hepatitis B in renal allograft recipients. Transplantation proceedings, 2003, Volume: 35, Issue:7 Topics: Adult; Female; Follow-Up Studies; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Liver Function Tests; Male; Middle Aged; Postoperative Complications; Reverse Transcriptase Inhibitors; Safety	2003
[Prevention and treatment of hepatitis B virus reinfection after liver transplantation]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2004, Volume: 12, Issue:6 Topics: Antiviral Agents; Female; Hepatitis B, Chronic; Humans; Immunization, Passive; Lamivudine; Liver Transplantation; Male; Postoperative Complications; Secondary Prevention	2004
Prevention of hepatitis B virus reinfection after orthotopic liver transplantation. Hepatobiliary & pancreatic diseases international : HBPD INT, 2004, Volume: 3, Issue:3 Topics: Adenine; Adult; Combined Modality Therapy; Female; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Postoperative Complications; Reverse Transcriptase Inhibitors; Secondary Prevention	2004
Adefovir dipivoxil as the rescue therapy for lamivudine-resistant hepatitis B post liver transplant. Transplantation proceedings, 2004, Volume: 36, Issue:8 Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; Child; Drug Resistance; Follow-Up Studies; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Middle Aged; Organophosphonates; Postoperative Complications; Recurrence; Retrospective Studies	2004
Acceptable recipient outcomes with the use of hearts from donors with hepatitis-B core antibodies. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2005, Volume: 24, Issue:1 Topics: Adult; Aged; Female; Heart Transplantation; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; New York; Postoperative Complications; Retrospective Studies; Reverse Transcriptase Inhibitors; Survival Analysis; Treatment Outcome	2005
[Comprehensive prophylaxis and treatment of hepatitis B recurrence after liver transplantation]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2005, Volume: 27, Issue:4 Topics: Combined Modality Therapy; Hepatitis B Antibodies; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Postoperative Complications; Secondary Prevention	2005
Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2006, Volume: 12, Issue:2 Topics: Adult; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Hepatitis B, Chronic; Humans; Immunoglobulins; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Probability; Retrospective Studies; Risk Assessment; Secondary Prevention; Statistics, Nonparametric; Treatment Outcome	2006
Treatment of lamivudine-resistant hepatitis B infection in post-renal transplant patients with adefovir dipivoxil: preliminary results. Transplantation proceedings, 2006, Volume: 38, Issue:9 Topics: Adenine; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Follow-Up Studies; Hepatitis B; Hepatitis B Core Antigens; Humans; Kidney; Kidney Transplantation; Lamivudine; Middle Aged; Organophosphonates; Postoperative Complications	2006
Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation. Gastroenterology, 2007, Volume: 132, Issue:3 Topics: Adult; Aged; Antiviral Agents; Australia; Disease-Free Survival; DNA, Viral; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Injections, Intramuscular; Kaplan-Meier Estimate; Lamivudine; Liver Diseases; Liver Transplantation; Male; Middle Aged; New Zealand; Postoperative Complications; Predictive Value of Tests; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Secondary Prevention; Time Factors; Treatment Outcome	2007
Role of lamivudine in the posttransplant prophylaxis of chronic hepatitis B virus and hepatitis delta virus coinfection. Transplantation, 2007, May-27, Volume: 83, Issue:10 Topics: Adult; Carcinoma, Hepatocellular; Female; Hepatitis B, Chronic; Hepatitis D; Humans; Immunoglobulins; Lamivudine; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Reoperation; Retrospective Studies; Reverse Transcriptase Inhibitors; Survival Analysis	2007
Antiviral prophylaxis and recurrence of hepatocellular carcinoma following liver transplantation in patients with hepatitis B. Transplantation proceedings, 2007, Volume: 39, Issue:10 Topics: Analysis of Variance; Antiviral Agents; Carcinoma, Hepatocellular; Disease-Free Survival; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Neoplasms; Neoplasm Staging; Postoperative Complications; Recurrence; Retrospective Studies; Survival Analysis; Survivors; Time Factors; Virus Diseases	2007
Changes in serological markers of hepatitis B virus after renal transplantation. Transplantation proceedings, 2008, Volume: 40, Issue:3 Topics: Antiviral Agents; Hepatitis B; Hepatitis B e Antigens; Humans; Kidney Transplantation; Lamivudine; Postoperative Complications; Prevalence; Retrospective Studies; Treatment Outcome	2008
Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology (Baltimore, Md.), 1996, Volume: 24, Issue:3 Topics: Adult; Antiviral Agents; Base Sequence; Conserved Sequence; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Molecular Probes; Molecular Sequence Data; Mutation; Postoperative Complications; Recurrence; RNA, Viral; Viremia	1996
[Preventive lamivudine against reinfection by hepatitis B after liver transplantation]. Zeitschrift fur Gastroenterologie, 1997, Volume: 35, Issue:5 Topics: Follow-Up Studies; Hepatitis B; Hepatitis, Chronic; Humans; Lamivudine; Liver Transplantation; Postoperative Complications; Premedication; Recurrence; Reverse Transcriptase Inhibitors	1997
Postliver transplant allograft reinfection with a lamivudine-resistant strain of hepatitis B virus: long-term follow-up. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 1998, Volume: 12, Issue:2 Topics: 2-Aminopurine; Adult; Antiviral Agents; Drug Resistance, Microbial; Famciclovir; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Time Factors	1998
[Prevention of hepatitis B--analysis of cost-effectiveness after liver transplantation]. Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress, 1997, Volume: 114 Topics: 2-Aminopurine; Adult; Antiviral Agents; Cost-Benefit Analysis; Famciclovir; Female; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence	1997
Effectiveness of lamivudine in treatment of acute recurrent hepatitis B after liver transplantation. Digestive diseases and sciences, 1998, Volume: 43, Issue:6 Topics: Acute Disease; Bilirubin; DNA, Viral; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Postoperative Complications; Recurrence; Reverse Transcriptase Inhibitors; Transaminases	1998
Efficacy of lamivudine re-treatment in a patient with hepatitis B virus (HBV) recurrence after liver transplantation and HBV-DNA breakthrough during the first treatment. Transplantation, 1998, Jun-15, Volume: 65, Issue:11 Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Retreatment	1998
Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology (Baltimore, Md.), 1998, Volume: 28, Issue:2 Topics: Adult; Aged; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Postoperative Care; Postoperative Complications; Preoperative Care; Reverse Transcriptase Inhibitors; Secondary Prevention; Virus Replication	1998
Lamivudine inhibits hepatitis B virus replication in kidney graft recipients. Transplantation, 1998, Aug-15, Volume: 66, Issue:3 Topics: Adult; Antiviral Agents; Drug Resistance, Microbial; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Postoperative Complications; Substance Withdrawal Syndrome; Virus Replication	1998
Lamivudine therapy of hepatitis B virus-related liver disease: cirrhosis, posttransplantation recurrence, and de novo infection. Transplantation proceedings, 1999, Volume: 31, Issue:6 Topics: Adult; Aged; Female; Follow-Up Studies; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Reverse Transcriptase Inhibitors	1999
Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation. Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 1999, Volume: 5, Issue:6 Topics: Administration, Oral; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Injections, Intramuscular; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Reverse Transcriptase Inhibitors; Time Factors	1999
Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient. Gut, 2000, Volume: 46, Issue:1 Topics: Adult; Antiviral Agents; Drug Resistance, Microbial; Female; Follow-Up Studies; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications	2000
Lamivudine for hepatitis B in liver transplantation: a single-center experience. Transplantation, 2000, Apr-15, Volume: 69, Issue:7 Topics: Adult; Aged; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Postoperative Care; Postoperative Complications; Preoperative Care; Recurrence; Reverse Transcriptase Inhibitors; Virus Replication	2000
Additional interferon alpha for lamivudine resistant hepatitis B infection after liver transplantation: a preliminary report. Transplantation, 2000, Apr-27, Volume: 69, Issue:8 Topics: Adult; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Drug Resistance; Drug Therapy, Combination; Hepatitis B; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recombinant Proteins; Retrospective Studies; Reverse Transcriptase Inhibitors	2000
Assessing virologic efficacy of combination lamivudine and low-dose hepatitis B immune globulin posttransplantation with the ultrasensitive digene hybrid capture II assay. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2000, Volume: 6, Issue:3 Topics: DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Postoperative Complications	2000
Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2000, Volume: 6, Issue:4 Topics: Adult; Combined Modality Therapy; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Immunoglobulins, Intravenous; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Secondary Prevention	2000
Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2000, Volume: 6, Issue:4 Topics: Adult; Aged; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunization, Passive; Immunoglobulins; Immunoglobulins, Intravenous; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Secondary Prevention	2000
Antiviral combination therapy for lamivudine-resistant hepatitis B reinfection after liver transplantation. Transplant international : official journal of the European Society for Organ Transplantation, 2000, Volume: 13 Suppl 1 Topics: 2-Aminopurine; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; Famciclovir; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Transplantation; Middle Aged; Postoperative Complications; Recombinant Proteins; Recurrence; Retrospective Studies; Time Factors; Virus Replication	2000
Managing hepatitis B reactivation in renal transplant recipients: a 12-year review with emphasis on early detection and early use of lamivudine. Transplantation proceedings, 2000, Volume: 32, Issue:7 Topics: Adult; Antiviral Agents; Carrier State; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Liver Function Tests; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Survival Analysis; Treatment Outcome	2000
Lamivudine improves the prognosis of patients with hepatitis B after liver transplantation. Transplantation proceedings, 2000, Volume: 32, Issue:7 Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Follow-Up Studies; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Postoperative Complications; Prodrugs; Prognosis; Recurrence; Retrospective Studies; Time Factors; Treatment Failure; Treatment Outcome	2000
Chronic hepatitis B treatment with lamivudine in kidney transplant patients. Transplantation proceedings, 2000, Volume: 32, Issue:8 Topics: Adult; Antiviral Agents; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Liver Function Tests; Postoperative Complications; Retrospective Studies	2000
Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2001, Volume: 7, Issue:2 Topics: Adult; Antiviral Agents; DNA, Viral; Female; Fibrosis; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Postoperative Complications	2001
Outcome of lamivudine resistant hepatitis B virus infection in liver transplant recipients in Singapore. Gut, 2000, Volume: 47, Issue:5 Topics: Antiviral Agents; Drug Resistance, Microbial; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Postoperative Complications; Treatment Outcome	2000
The real danger of lamivudine-resistant hepatitis B virus infection in the immunocompromised host. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2001, Volume: 7, Issue:3 Topics: Antiviral Agents; Chronic Disease; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Lamivudine; Liver Cirrhosis; Liver Transplantation; Postoperative Complications	2001
Outcome of lamivudine resistant hepatitis B virus infection in liver transplant recipients in Singapore. Gut, 2001, Volume: 48, Issue:4 Topics: Antiviral Agents; Drug Resistance, Microbial; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Postoperative Complications; Treatment Outcome	2001
Orthotopic liver transplantation in patients with hepatitis B-related liver disease. Transplantation proceedings, 2001, Volume: 33, Issue:4 Topics: Adolescent; Adult; Antiviral Agents; Carcinoma, Hepatocellular; Follow-Up Studies; Graft Rejection; Hepatitis B; Humans; Lamivudine; Liver Neoplasms; Liver Transplantation; Middle Aged; Postoperative Complications; Retrospective Studies; Survival Rate; Time Factors	2001
Severe clinical course of de novo hepatitis B infection after liver transplantation. Transplantation proceedings, 2001, Volume: 33, Issue:4 Topics: 2-Aminopurine; Adult; Antiviral Agents; Famciclovir; Fatal Outcome; Female; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Middle Aged; Postoperative Complications; Recurrence; Reoperation; Retrospective Studies; Treatment Outcome	2001
Efficacy of lamivudine for the treatment of hepatitis B virus infection after liver transplantation in children. Transplantation, 2001, Jul-27, Volume: 72, Issue:2 Topics: 2-Aminopurine; Adolescent; Alanine Transaminase; Antiviral Agents; Child; Child, Preschool; Cystic Fibrosis; DNA, Viral; Famciclovir; Female; Hepatitis A; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Hyperoxaluria; Lamivudine; Liver Failure; Liver Transplantation; Living Donors; Male; Postoperative Complications; Retrospective Studies; Time Factors	2001
Hepatitis B surface antigen-positive organ transplantation recipients: can lamivudine alter their fate? Journal of gastroenterology and hepatology, 2001, Volume: 16, Issue:9 Topics: Carrier State; Disease Progression; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Function Tests; Organ Transplantation; Postoperative Complications; Survival Rate; Transplantation Immunology; Treatment Outcome; Virus Activation	2001
Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: a 4-year experience. Journal of gastroenterology and hepatology, 2001, Volume: 16, Issue:9 Topics: Adult; Carrier State; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Function Tests; Male; Middle Aged; Organ Transplantation; Postoperative Complications; Retrospective Studies; Survival Rate; Transplantation Immunology; Virus Activation	2001
Efficacy of famciclovir in the treatment of lamivudine resistance related to an atypical hepatitis B virus mutant. Transplantation, 2002, Jan-15, Volume: 73, Issue:1 Topics: 2-Aminopurine; Adult; DNA, Viral; Drug Resistance, Microbial; Famciclovir; Female; Hepatitis B; Hepatitis B virus; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Mutation; Postoperative Complications	2002
[Orthotopic liver transplantation for end-stage liver diseases in 71 cases]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2002, Volume: 10, Issue:1 Topics: Adolescent; Adult; Biliary Tract Diseases; Child; Female; Follow-Up Studies; Hepatitis B; Humans; Lamivudine; Liver Diseases; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Survival Rate; Vascular Diseases	2002